380 related articles for article (PubMed ID: 21931765)
1. MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.
de Antonellis P; Medaglia C; Cusanelli E; Andolfo I; Liguori L; De Vita G; Carotenuto M; Bello A; Formiggini F; Galeone A; De Rosa G; Virgilio A; Scognamiglio I; Sciro M; Basso G; Schulte JH; Cinalli G; Iolascon A; Zollo M
PLoS One; 2011; 6(9):e24584. PubMed ID: 21931765
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.
Garzia L; Andolfo I; Cusanelli E; Marino N; Petrosino G; De Martino D; Esposito V; Galeone A; Navas L; Esposito S; Gargiulo S; Fattet S; Donofrio V; Cinalli G; Brunetti A; Vecchio LD; Northcott PA; Delattre O; Taylor MD; Iolascon A; Zollo M
PLoS One; 2009; 4(3):e4998. PubMed ID: 19308264
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.
Pang RT; Leung CO; Lee CL; Lam KK; Ye TM; Chiu PC; Yeung WS
BMC Cancer; 2013 Jan; 13():25. PubMed ID: 23327670
[TBL] [Abstract][Full Text] [Related]
4. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.
Xie ZY; Wang FF; Xiao ZH; Liu SF; Tang SL; Lai YL
J Biochem; 2020 Jun; 167(6):557-564. PubMed ID: 32044957
[TBL] [Abstract][Full Text] [Related]
5. LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p/DLL1 axis and activating Notch pathway in vitro and in vivo.
Xu Y; Qiu Z; Chen J; Huang L; Zhang J; Lin J
Drug Deliv Transl Res; 2024 Jul; 14(7):2003-2018. PubMed ID: 38161194
[TBL] [Abstract][Full Text] [Related]
6. MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene.
Pu Y; Zhao F; Wang H; Cai S
Sci Rep; 2017 Mar; 7():44218. PubMed ID: 28281638
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells.
Chen L; Holmstrøm K; Qiu W; Ditzel N; Shi K; Hokland L; Kassem M
Stem Cells; 2014 Apr; 32(4):902-12. PubMed ID: 24307639
[TBL] [Abstract][Full Text] [Related]
8. MiR-34a Enhances Chondrocyte Apoptosis, Senescence and Facilitates Development of Osteoarthritis by Targeting DLL1 and Regulating PI3K/AKT Pathway.
Zhang W; Hsu P; Zhong B; Guo S; Zhang C; Wang Y; Luo C; Zhan Y; Zhang C
Cell Physiol Biochem; 2018; 48(3):1304-1316. PubMed ID: 30048987
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells.
Du R; Sun W; Xia L; Zhao A; Yu Y; Zhao L; Wang H; Huang C; Sun S
PLoS One; 2012; 7(2):e30771. PubMed ID: 22363487
[TBL] [Abstract][Full Text] [Related]
10. Verification of microRNA expression in human endometrial adenocarcinoma.
Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
[TBL] [Abstract][Full Text] [Related]
11. Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma.
Teider N; Scott DK; Neiss A; Weeraratne SD; Amani VM; Wang Y; Marquez VE; Cho YJ; Pomeroy SL
Neuro Oncol; 2010 Dec; 12(12):1244-56. PubMed ID: 20847082
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-34a induces transdifferentiation of glioma stem cells into vascular endothelial cells by targeting Notch pathway.
Jin Z; Zhan T; Tao J; Xu B; Zheng H; Cheng Y; Yan B; Wang H; Lu G; Lin Y; Guo S
Biosci Biotechnol Biochem; 2017 Oct; 81(10):1899-1907. PubMed ID: 28859546
[TBL] [Abstract][Full Text] [Related]
13. MiR-34a represses Numbl in murine neural progenitor cells and antagonizes neuronal differentiation.
Fineberg SK; Datta P; Stein CS; Davidson BL
PLoS One; 2012; 7(6):e38562. PubMed ID: 22701667
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells.
Genovesi LA; Carter KW; Gottardo NG; Giles KM; Dallas PB
PLoS One; 2011; 6(9):e23935. PubMed ID: 21931624
[TBL] [Abstract][Full Text] [Related]
15. MiR-34a deficiency accelerates medulloblastoma formation in vivo.
Thor T; Künkele A; Pajtler KW; Wefers AK; Stephan H; Mestdagh P; Heukamp L; Hartmann W; Vandesompele J; Sadowski N; Becker L; Garrett L; Hölter SM; Horsch M; Calzada-Wack J; Klein-Rodewald T; Racz I; Zimmer A; Beckers J; Neff F; Klopstock T; De Antonellis P; Zollo M; Wurst W; Fuchs H; Gailus-Durner V; Schüller U; de Angelis MH; Eggert A; Schramm A; Schulte JH
Int J Cancer; 2015 May; 136(10):2293-303. PubMed ID: 25348795
[TBL] [Abstract][Full Text] [Related]
16. NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma.
Fiaschetti G; Schroeder C; Castelletti D; Arcaro A; Westermann F; Baumgartner M; Shalaby T; Grotzer MA
Acta Neuropathol Commun; 2014 Apr; 2():39. PubMed ID: 24708907
[TBL] [Abstract][Full Text] [Related]
17. The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.
Andolfo I; Liguori L; De Antonellis P; Cusanelli E; Marinaro F; Pistollato F; Garzia L; De Vita G; Petrosino G; Accordi B; Migliorati R; Basso G; Iolascon A; Cinalli G; Zollo M
Neuro Oncol; 2012 May; 14(5):596-612. PubMed ID: 22411914
[TBL] [Abstract][Full Text] [Related]
18. miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.
Weeraratne SD; Amani V; Neiss A; Teider N; Scott DK; Pomeroy SL; Cho YJ
Neuro Oncol; 2011 Feb; 13(2):165-75. PubMed ID: 21177782
[TBL] [Abstract][Full Text] [Related]
19. Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta/Notch pathway.
Marcet B; Chevalier B; Luxardi G; Coraux C; Zaragosi LE; Cibois M; Robbe-Sermesant K; Jolly T; Cardinaud B; Moreilhon C; Giovannini-Chami L; Nawrocki-Raby B; Birembaut P; Waldmann R; Kodjabachian L; Barbry P
Nat Cell Biol; 2011 Jun; 13(6):693-9. PubMed ID: 21602795
[TBL] [Abstract][Full Text] [Related]
20. Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma.
Bettinsoli P; Ferrari-Toninelli G; Bonini SA; Prandelli C; Memo M
BMC Cancer; 2017 May; 17(1):352. PubMed ID: 28525978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
